U. COLORADO (US) — When specific types of stem cells are transplanted into leg muscles of mice, normal loss of function that comes with aging is prevented.
The findings have potential uses in treating humans with chronic, degenerative muscle diseases, according to a new study.
Researchers found that when young host mice with limb muscle injuries were injected with muscle stem cells from young donor mice, the cells not only repaired the injury within days, they caused the treated muscle to double in mass and sustain itself through the lifetime of the transplanted mice.
“This was a very exciting and unexpected result,” says Bradley Olwin, professor of molecular, cellular, and developmental biology at the University of Colorado at Boulder.
Muscle stem cells are found within populations of “satellite” cells located between muscle fibers and surrounding connective tissue and are responsible for the repair and maintenance of skeletal muscles, Olwin explains.
Researchers transplanted between 10 and 50 stem cells along with attached myofibers—which are individual skeletal muscle cells—from the donor mice into the host mice.
“We found that the transplanted stem cells are permanently altered and reduce the aging of the transplanted muscle, maintaining strength and mass,” says Olwin.
Details of the research are published in the Nov. 10 issue of Science Translational Medicine.
The new findings, while intriguing, are only the first in discovering how such research might someday be applicable to human health, Olwin says.
“With further research we may one day be able to greatly resist the loss of muscle mass, size and strength in humans that accompanies aging, as well as chronic degenerative diseases like muscular dystrophy.”
Stem cells are distinguished by their ability to renew themselves through cell division and differentiate into specialized cell types. In healthy skeletal muscle tissue, the population of satellite stem cells is constantly maintained.
“In this study, the hallmarks we see with the aging of muscles just weren’t occurring,” Olwin says. “The transplanted material seemed to kick the stem cells to a high gear for self-renewal, essentially taking over the production of muscle cells.
“But the team found that when transplanted stem cells and associated myofibers were injected to healthy mouse limb muscles, there was no discernable evidence for muscle mass growth.
“The environment that the stem cells are injected into is very important, because when it tells the cells there is an injury, they respond in a unique way,” he explains.
“We don’t yet know why the cells we transplanted are not responding to the environment around them in the way that the cells that are already there respond. It’s fascinating, and something we need to understand.”
At the onset of the experiments the research team thought the increase in muscle mass of the transplanted mice with injured legs would dissipate within a few months.
Instead, the cells underwent a 50 percent increase in mass and a 170 percent increase in size and remained elevated through the lifetime of the mice—roughly two years.
In the experiments, stem cells and myofibers were removed from three-month-old mice, briefly cultured and then transplanted into three-month-old mice that had temporarily induced leg muscle injuries produced by barium chloride injections.
“When the muscles were examined two years later, we found the procedure permanently changed the transplanted cells, making them resistant to the aging process in the muscle,” he says.
“This suggests a tremendous expansion of those stem cells after transplantation.”
Fortunately, the research team saw no increase in tumors in the transplanted mice despite the rapid, increased growth and production of muscle stem cells.
As part of the research effort, the team used green fluorescent protein—which glows under ultraviolet light—to flag donor cells in the injected mice.
The experiment indicated many of the transplanted cells were repeatedly fused to myofibers, and that there was a large increase in the number of satellite cells in the host mice.
“We expected the cells to go in, repopulate and repair damaged muscle and to dissipate,” Olwin says. “It was quite surprising when they did not.
“It is our hope that we can someday identify small molecules or combinations of small molecules that could be applied to endogenous muscle stem cells of humans to mimic the behavior of transplanted cells.
“This would remove the need for cell transplants altogether, reducing the risk and complexity of treatments.”
But Olwin said it is important to remember that the team did not transplant young cells into old muscles, but rather transplanted young cells into young muscles.
The research has implications for a number of human diseases, Olwin says.
In muscular dystrophy, for example, there is a loss of a protein called dystrophin that causes the muscle to literally tear itself apart and cannot be repaired without cell-based intervention. Although injected cells will repair the muscle fibers, maintaining the muscle fibers requires additional cell injections, he said.
“Progressive muscle loss occurs in a number of neuromuscular diseases and in muscular dystrophies,” he says.
“Augmenting a patient’s muscle regenerative process could have a significant impact on aging and diseases, improving the quality of life and possibly improving mobility.”
Olwin is beginning experiments to see if transplanting muscle stem cells from humans or large animals into mice will have the same effects as those observed in the recent mouse experiments.
“If those experiments produce positive results, it would suggest that transplanting human muscle stem cells is feasible.”
Scientists from the University of Washington contributed to the research, which was funded in part by the National Institutes of Health and the Muscular Dystrophy Association.
More news from University of Colorado: www.colorado.edu/news/